Moderate evidence exists for four microRNAs as potential biomarkers for tendinopathies and degenerative tendon ruptures at the upper extremity in elderly patients: conclusion of a systematic review with best‐evidence synthesis

Abstract

Abstract Purpose The aim of this systematic review was to investigate tendon‐specific microRNAs (miRNAs) as biomarkers for the detection of tendinopathies or degenerative tendon ruptures. Also, their regulatory mechanisms within the tendon pathophysiology were summarized. Methods A systematic literature research was performed using the PRISMA guidelines. The search was conducted in the Pubmed database. The SIGN checklist was used to assess the study quality of the included original studies. To determine the evidence and direction of the miRNA expression rates, a best‐evidence synthesis was carried out, whereby only studies with at least a borderline methodological quality were considered for validity purposes. Results Three thousand three hundred seventy studies were reviewed from which 22 fulfilled the inclusion criteria. Moderate evidence was found for miR‐140‐3p and miR‐425‐5p as potential biomarkers for tendinopathies as well as for miR‐25‐3p, miR‐29a‐3p, miR‐140‐3p, and miR‐425‐5p for the detection of degenerative tendon ruptures. This evidence applies to tendons at the upper extremity in elderly patients. All miRNAs were associated with inflammatory cytokines as interleukin‐6 or interleukin‐1ß and tumor necrosis factor alpha. Conclusions Moderate evidence exists for four miRNAs as potential biomarkers for tendinopathies and degenerative tendon ruptures at the upper extremity in elderly patients. The identified miRNAs are associated with inflammatory processes.

Keywords

• Circulating RNA
• Ci‐miRNA
• Micro‐RNA
• miRNA
• Connective tissue
• Tendinopathy